MULTIDRUG RESISTANCE OF Klebsiella pneumoniae IN CATS IN BOGOR, INDONESIA by Ramadhan, Juliadi et al.
Jurnal Kedokteran Hewan June 2021, 15(2):47-52 
P-ISSN : 1978-225X; E-ISSN : 2502-5600  DOI: https://doi.org/10.21157/j.ked.hewan.v15i2.17882 
 
47 
MULTIDRUG RESISTANCE OF Klebsiella pneumoniae IN CATS 






*, and Ni Luh Putu Ika Mayasari
2 
1Post Graduate of Medical Microbiology, Faculty Veterinary Medicine, IPB University, Bogor, Indonesia 
2Division of Medical Microbiology, Department of Animal Diseases and Veterinary Health, Veterinary Association of Faculty of 
Veterinary Medicine IPB University, Bogor, Indonesia 




This study aims to measure the level of antibiotic resistance to Klebsiella pneumoniae isolated from clinical cats in Bogor. Samples were 
isolated and identified macroscopically, microscopically, and biochemically. Positive isolates were tested for antibiotic sensitivity using the 
Kirby-Bauer disk diffusion method. The results showed that Klebsiella pneumoniae isolated from sputum and laryngeal swabs of clinic cats in 
Bogor had experienced Multidrug Resistance (MDR). The highest level of resistance to Klebsiella pneumoniae occurred in the β-lactam group 
(amphicillin 76%) followed by the tetracycline group (oxytetracycline 72% and tetracycline 68%), then the quinolone group (enrofloxacin 52%), 
and finally the aminoglycoside group (gentamicin 44%). The results of this study are expected to be taken into consideration in the use of 
antibiotics for the treatment of cases related to the Klebsiella pneumoniae bacteria. 
____________________________________________________________________________________________________________________ 




Penelitian ini bertujuan mengukur tingkat resistensi antibiotika terhadap Klebsiella pneumonia yang diisolasi dari kucing klinik hewan di 
kota Bogor. Sampel diisolasi dan diidentifikasi secara makroskopis, mikroskopis, dan biokimia. Isolat positif dilakukan uji sensitivitas terhadap 
antibiotik menggunakan metode Kirby-Bauer disk diffusion. Hasil penelitian menunjukkan bahwa isolat Klebsiella pneumonia yang diisolasi dari 
sputum dan usap laring pada kucing klinik di kota Bogor telah mengalami Multi Drug Resistant (MDR). Tingkat resistensi Klebsiella pneumonia 
tertinggi terjadi pada golongan β-laktam (ampisilin76%) yang diikuti oleh golongan tetrasiklin (oksitetrasiklin 72% dan tetrasiklin 68%), 
golongan kuinolon (enrofloksasin52%), serta golongan aminoglikosida (gentamisin 44%). Hasil dari penelitian ini diharapkan dapat menjadi 
bahan pertimbangan dalam pemakaian antibiotika untuk pengobatan kasus terkait dengan bakteri Klebsiella pneumoniae. 
____________________________________________________________________________________________________________________ 





Klebsiella pneumoniae (K. pneumoniae) belongs to 
the Enterobactericeae family, which is a Gram negative 
bacterium in the form of bacilli (Podschun and Ullmann, 
1998). K. pneumoniae has been described as an agent 
of Friedlander's pneumonia, which is a severe lobar 
pneumonia with a high mortality rate. K. pneumoniae is 
still one of the main causes of pneumonia in several 
countries (Brisse et al., 2009). These bacteria can form a 
capsule (Podschun and Ullmann, 1998), and this capsule 
that surrounds K. pneumoniae serves to protect against 
phagocytosis activity and bactericidal serum. This is 
considered to be the most important determinant of K. 
pneumoniae virulence (Brisse et al., 2009). Other factors 
involved in the virulence of the K. pneumoniae strain 
include capsular serotype, lipopolysaccharide, iron 
scavenging system, fimbrial and nonfimbrial adhesion. 
Historically, this species of bacteria, in addition to 
causing upper respiratory tract infections (Adler et al., 
2007), has also been shown to cause urinary tract 
infections (Ling et al., 2001), pyometra (Stone et al., 
1988), and septicemia (Roberts et al., 2000). 
The existence of a bacterial infection can be 
overcome by administering antibacterial through 
antibiotics. Antibiotics are chemical substances 
produced by microbes with antimicrobial properties 
(Entjang, 2003). According to Boogard (2001), based 
on field observations, the antibiotics commonly used 
for the prevention and treatment of disease in animals 
are penicillin, tetracycline, and sulfonamide antibiotics. 
Inaccurate selection of antibiotics, indications, dosage, 
administration method, frequency, and duration of 
administration are the causes of inaccurate treatment of 
infection with antibiotics (Nelson, 1995). A study 
conducted in Japan, reported that there was a positive 
relationship between antibiotic use and the level of 
resistance that occurred (Asai et al., 2005). The 
careless or inappropriate use of antibiotics, in addition 
to failing therapy, can also cause other dangers such as 
resistance, Multidrug Resistance (MDR), supra 
infection, and other negative side effects 
(Sastramihardja and Hendry, 1997). 
MDR is the bacterial resistance to three or more 
antibiotic groups (Magiorakos et al., 2012). MDR in 
bacteria is caused by two mechanisms. First, the 
accumulation of several genes encoding a trait that is 
resistant to one antibiotic in a single cell. This 
accumulation occurs in the R (resistance) plasmid. 
Second, the increased of gene expression which 
responsible for coding the efflux pump against several 
antibiotics (Nikaido, 2009). Many cases of MDR        
K. pneumoniae have been found at several parts of this 
world, among others, in Tunis-Tunisia, Capetown-
South Africa, and Shijiazuang-China (Messaoudi et al., 
2009; Fielding et al., 2012; Guo et al., 2016). 
Antibiotic resistance to Klebsiella spp. has become 
a major concern around the world (Lynch et al., 2013). 
In recent years, research about antibiotic resistance 
to Klebsiella spp. in pets has been published in several 
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countries in Europe, including Germany (Stolle et al., 
2013; Ewers et al., 2014), Italy (Donati et al., 2014), 
France (Haenni et al., 2012; Poirel et al., 2013), Spain 
(Hidalgo et al., 2013), and Switzerland (Wohlwend et 
al., 2015). Brisse and Duijkeren (2005) stated that      
K. pneumoniae isolates collected from dogs and cats 
were resistant to ampicillin, chepalexin, ceftacidime, 
enrofloxacin, gentamicin, and tetracyclines. 
The incidence of bacterial resistance to antibiotics is 
very essential to note because it has been shown that 
bacteria that have developed resistance can cause 
serious illness in pets and can complicate treatment. 
Therefore, it is necessary to study the resistance of K. 
pneumoniae bacteria to several antibiotics in cats from 
animal clinics in Bogor. 
  
MATERIALS AND METHODS 
 
Isolation and Identification 
The samples used in this study were sputum 
samples and laryngeal swabs from cats that were 
hospitalized at the veterinary clinic in Bogor.              
K. pneumoniae bacteria can cause upper respiratory 
tract infections (Adler et al., 2007), thus bacteria 
isolation through sputum and laryngeal swabs is a 
proper method to be done. Samples were taken from 10 
clinics with a total of 58 samples. Samples were put 
into 0.1% buffer peptone water (BPW) and stored at   
4° C. The sputum samples and laryngeal swabs were 
cultured in Mac Conkey Agar (MCA) media by taking 
samples using ose and cultured on MCA media then 
incubated at 37° C for 24 hours. Microscopic 
observation using Gram staining was done by taking 
one loop of bacteria swab with sterile physiological 
NaCl and fixed on microscope slides, followed by 
giving crystal violet solution for 3 minutes, lugol for 1 
minute, 95% acetone alcohol for 30 seconds and 
safranin for 2 minutes. The bacteria morphology was 
observed under a microscope at 10×100 magnification. 
Gram positive bacteria will provide purple color while 
Gram negative bacteria will develop red colour (Willey 
et al., 2008). The morphology of the genus Klebsiella 
bacteria has a stem, mucoid shape and is characteristic 
red of Gram negative bacteria. 
 
Confirmation with Biochemistry Test  
A single colony suspected of being genus Klebsiella 
bacteria was then subcultured on Triptic Soy Agar 
(TSA) agar media by inoculating one bacterial colony 
with ose derived from MCA media and cultured on 
TSA media then incubated at 37° C for 24 hours. 
Bacteria suspected to be colonies of genus 
Klebsiella bacteria on macroscopic examination were 
then identified using biochemical tests. The 
biochemical tests carried out were the Triple Sugar Iron 
Agar (TSIA) test, Urease test, IMVIC test consisting of 
Sulfide Indole Motility (SIM) test, the Methyl Red-
Voges Proskauer (MRVP) test, Simmon's Citrate test, 
and fermentation tests of glucose, lactose, sucrose, 
maltose, dulsitol, and mannitol. 
Triple Sugar Iron Agar (TSIA) test was iniated by 
taking a macroscopic loop of positive K. pneumoniae 
bacteria and scratching it on the surface of the TSA 
agar slant. There are 3 indicators can be seen in the 
TSIA test: the formation of gas which is indicated by 
the formation of air cavities in the media; the ability to 
ferment carbohydrates which is marked by a change in 
color on the media to yellow; and the ability to produce 
H2S which is indicated by the black color presence in 
the media. The TSIA media is an enriched medium 
used for bacterial differentiation based on its ability to 
ferment glucose, lactose, sucrose and to reduce sulfur 
(Laboffe and Burton, 2011). 
The motility test was started with the inoculation of 
bacteria on the SIM medium by vertically stabbing on 
the media and incubating it at 37° C for 24 hours, a 
positive result for the motility test was indicated by the 
presence of bacterial growth in the puncture area and 
spread to the media surface. In indol test, 2-3 drops of 
Earlich's reagent was added to the same media as the 
motility test, then left it for 5 seconds. A positive result 
was indicated by the formation of a red ring. 
The MR test was conducted by inoculating bacteria 
on the methyl red medium and then 3-5 drops of methyl 
red reagent were added. Positive results were indicated 
by color change of the media from yellow to red. The 
VP test was carried out by adding 5 drops of VP 
reagent (α napthol) and 5 drops of 40% KOH to the 
media, homogenized and then let it for 5-10 minutes. A 
positive result was indicated by color change of media 
from yellow to red (Markey et al., 2013). 
Simmon's Citrate test using Simmon's Citrate Agar 
(SCA) media with the inoculation process was carried 
out on the media surface and incubated at 37° C for 24 
hours. A positive result was indicated by color change 
of the media from green to blue, and the negative result 
shows no color change. 
The fermentation test for the sugars was begun with 
the inoculation of bacteria in each medium consisting 
of glucose, lactose, sucrose, maltose, dulsitol, and 
mannitol then incubated at 37° C for 24 hours. Positive 
results for the sugar fermentation test in each medium 
were indicated by a change in color from red to yellow. 
 
Antibiotic Resistance Test using Kirby-Bauer Disk 
Diffusion Method  
The antibiotic sensitivity test followed the Kirby-
Bauer disk diffusion method using Mueller-Hinton agar 
based on the Clinical and Laboratory Standards 
Institute Guidelines (CLSI, 2018) (Table 1). The 
sample tested was a sample that shows a positive result 
in the Biochemical test. The bacterial colonies obtained 
from TSA were diluted with physiological NaCl until 
they reached the Mcfarland standard 0.5 or equivalent 
to 1.5×10
8
 CFU/mL, 1 mL suspension was poured on 
Muller-Hilton agar. Diffusion disks containing 
antibiotics were placed on the surface Muller-Hilton 
uses sterile tweezers then incubated at 35° C for 16-18 
hours and the inhibition zone was measured by 
referring to the CLSI (2018). Antibiotics used were 
ampicillin 10 µg, tetracycline 30 µg, oxytetracycline 30 
µg, gentamicin 10 µg, and enrofloxacin 5 µg. This 
sensitivity test was replicated 3 times. 
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RESULT AND DISCUSSION  
 
Isolation and Identification   
Sputum and laryngeal swab samples were isolated 
and identified and 49 out of 58 samples (84.48%) 
which were cultured on MCA media showing the 
bacteria growth of genus Klebsiella.The quantity of the 
sample size was adjusted to the capacity of the in-
patient room and the intensity of antibiotic use. In each 
animal clinic, from the isolated samples it was found 
bacteria that had pink, convex, and mucoid colony 
which are characteristic of the genus 
Klebsiella bacteria. When investigating the colony 
variant K. pneumoniae, Julianelle (1928) reported that 
the K. pneumoniae colony had a mucoid shape and was 
slightly slimy. The mucoid colony form of                  
K. pneumoniae was also reported by Hadley (1925) and 
O'Neal (1933). Burke (2009) stated that the presence of 
hypermucoviscous and lactose fermentation also 
occurred in the K. pneumoniae colonies, resulting in a 
color change in the color of the MCA media to pink. 
Mucoid colonies of the genus Klebsiella bacteria are 
pictured in Figure 1a. Gram staining was conducted in 
order to see the shape of the bacteria. Klebsiella has a 
rod shape with red color which is characteristic of 
Gram negative bacteria (Figure 1b). 
Confirmation of bacteria using the IMViC test 
showed that 51% (25/49) of the samples illustrated the 
biochemical properties of K. pneumoniae, namely 
positive for Indole, negative for bacterial motility in the 
SIM test, positive for the Methyl Red test, negative for 
the Voges-Proskauer test, positive for the Simmon's 
Citrate test, positive for the Urease test, negative for 
H2S, positive for gas and sugar fermentation in the 
TSIA test, and positive for the fermentation test for 
glucose, lactose, sucrose, maltose, dulsitol, and 
mannitol (Holt and Krieg, 1994). Brisse et al. (2009) 
stated that K. pneumoniae is nonmotile bacteria, does 
not produce H2S, and shows positive result in the 
Simmon’s citrate test. Brown and Ramon (1973) also 
stated that these bacteria are not motile, and rapidly 
ferment maltose and mannitol.  
K. pneumoniae is a Gram negative bacterium with 
size around 2.0-3.0×0.6 μm, and one of facultative 
anaerobes common flora found in the intestinal and 
respiratory tract. K. pneumoniae has a large capsule, 
thus the colony culture looks very mucoid.                  
K. pneumoniae is unable to move because it does not 
have a flagellum, but is able to ferment carbohydrates 
to form acids and gases. Based on their need for 
oxygen, K. pneumoniae is a facultative anaerobic 
bacterium. K. pneumoniae species showed growth of 
mucoid, large, nonmotile capsule polysaccharide 
(Anderson et al., 2007). 
Factors involved in the virulence of the                  
K. pneumoniae strain include capsular serotype, 
lipopolysaccharide, iron scavenging system, fimbrial 
and nonfimbrial adhesion. The polysaccharide capsules 
surrounding K. pneumoniae protect against 
phagocytosis activity and bactericidal serum considered 
as the most important virulence determinant of            
K. pneumoniae (Brisse et al., 2009). 
These bacteria cause infections in the lungs, such as 
pneumonia, urinary tract infections, and sepsis in 
patients with weak immune systems (Brooks et al., 
2005). K. pneumoniae causes extensive consolidation 
accompanied by hemorrhagic necrosis of the lung. These 
organisms sometimes cause urinary tract infections and 
bacteremia accompanied by focal infections in severe 
debilitated patients (Carpenter, 1990). 
 
Resistance Test of Klebsiella pneumoniae against 
Antibiotic  
The resistance test was carried out by calculating 
the diameter of the antibiotic inhibition zone formed on 
the Mueller-Hinton agar medium, then the results of the 
antibiotic resistance test were correlated with CLSI 
(2018) guidelines (Table 1). The results showed that   
Table 1. Standard diameter of the inhibition zone (CLSI, 2018)  
Type of antibiotic  
Dose 
(µg) 
Inhibition zone (mm) 
S I R 
Ampicillin (AMP) 10 ≥17 14-16 ≤13 
Gentamicin (CN) 10 ≥15 13-14 ≤12 
Tetrasiklin (TET) 30 ≥15 12-14 ≤11 
Oxytetracycline (OT) 30 ≥19 15-18 ≤14 
Enrofloxacin (EN) 5 ≥23 14-22 ≤13 
S= Susceptible, I= Intermediate, R= Resistant 
 
 
Figure 1. Klebsiella bacteria isolation of sputum samples and laryngeal swabs. 1a= Colonies form on MCA, 1b= Bacteria shape after 
Gram staining 
1a 1b 
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K. pneumoniae against 5 antibiotics showed a high 
level of resistance. Overall, the isolates used in this 
study were resistant to at least three types of antibiotics. 
This study was conducted on 10 veterinary clinics 
in Bogor with a different number of samples from each 
clinic. The most positive samples of K. pneumoniae 
came from clinic 7 (7 samples), while the smallest 
number of samples came from clinics 4, 8, and 10, 
which were 1 sample, but for clinics 5 and 9 there were 
no typical K. pneumoniae colonies found on MCA 
media. Thus, these colonies were not included in the 
resistance test. 
Table 3 shows the different levels of antibiotic 
resistance to K. pneumoniae isolates used in this study. 
The resistance incidence for the β-lactam (ampicillin) 
group and the tetracycline (tetracycline) group was 
found in 7 out of 10 clinics (70%), while for the 
tetracycline (oxytetracycline) group was found in 6 out 
of 10 clinics (60%). Quinolone (enrofloxacin) group 
resistance was found in 5 out of 10 clinics (50%), but 
for the aminoglycoside (gentamicin) group it was found 
only in 4 out of 10 clinics (40%). This study results 
similar to Haenni et al. (2012) as K. pneumoniae 
isolated from dogs and cats were resistant to antibiotics 
of tetracycline, quinolone, and aminoglycosides. 
The resistant incidence in K. pneumoniae isolates to 
antibiotics can occur due to various factors, including 
the use of antibiotics for a long time, excessive use and 
inappropriate dosage. Bartlett et al. (2013) explained 
that the excessive use of antibiotics has led to a global 
crisis of antibiotic resistance. Venezia et al. (2017) 
explained that K. pneumoniae bacteria are a source of 
the spread of resistance to antibiotics. K. pneumoniae 
continuously accumulates antibiotic resistance genes 
(ARGs) through denovo mutations, plasmid 
acquisition, and transferable genetic elements. These 
bacteria that produce extended spectrum beta lactamase 
(ESBL) have a higher level of risk and malignancy, and 
result in longer time of recovery for sick people 
(Tumbarello et al., 2006). The presence of antibiotic 
resistance genes causes bacteria to have resistant 
properties. The nature of antibiotic resistance in 
bacteria serves to protect itself from harmful agents 
(Cogliani et al., 2011). 
The highest pattern of K. pneumoniae resistance 
occurred in the β-lactam group of antibiotics 
(ampicillin), while the lowest was the aminoglycoside 
group of antibiotics (gentamicin), for the quinolone 
group (enrofloxacin), while for the tetracycline group 
(tetracycline and oxytetracycline) (Table 4). The 
Table 2. Isolation and identificationof Klebsiella spp. from cats in Bogor 
Sample source Number of samples Positive Negative 
Clinic 1 10 90% (9) 10% (1) 
Clinic 2 6 100% (6) 0% (0) 
Clinic 3 8 75% (6) 25% (2) 
Clinic 4 2 100% (2) 0% (0) 
Clinic 5 3 0% (0) 100% (3) 
Clinic 6 5 80% (4) 20% (1) 
Clinic 7 9 100% (9) 0% (0) 
Clinic 8 2 100% (2) 0% (0) 
Clinic 9 5 20% (1) 80% (4) 
 Clinic 10 8 12,5% (1) 87,5% (7) 
Total  58 84.48% (49) 15.51% (9) 
 




Antibiotic resistance pattern (%) 
Amphicillin Enrofloxacin Gentamicin Tetracyclines  Oxytetracycline 





















































































































































































R= Resistant, I= Intermediate, S= Sensitive, K1-K10= Clinical code 
 
Table 4. Percentage of antibiotic resistance in Klebsiella pneumoniae bacteria (n= 25) 
Type of antibiotic S I R Percentage (%) 
Amphicillin 1 4 19 76 
Gentamicin 13 1 11 44 
Tetracyclines 4 4 17 68 
Oxytetracycline 7 0 18 72 
Enrofloxacin 12 0 13 52 
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incidence of K. pneumoniae resistance in pets (dogs and 
cats) is closely related to the prolonged use of antibiotics 
and treatment of nonbacterial causal diseases to avoid 
secondary infections (Rzewuska et al., 2015). The         
β-lactam group and the tetracycline group are still the 
main choices and are most often used for therapy in cats 
because of their effectiveness against Gram positive and 
Gram negative bacteria. Carvalho et al. (2020) stated 
that K. pneumoniae isolates from domestic animals were 
resistant to the β-lactam group. Haenni et al. (2012) 
stated that in addition to β-lactam resistance, it turns out 
that K. pneumoniae isolates from dogs and cats are also 
resistant to several other antibiotic groups such as 
aminoglycosides, tetracyclines, and quinolones. Jassim 
et al. (2019) stated that one of the antibiotics with the 
highest level of resistance in veterinary clinics was the 
tetracycline group. 
K. pneumoniae isolate in this study was resistant to 
more than one group of antibiotics, which is commonly 
known as MDR. Oliva et al. (2015) noted the 
widespread use and abuse of antimicrobial agents to 
treat disease in animals, K. pneumoniae has become 
highly resistant to most antibiotics. Ripabelli et 
al. (2018) stated that the emergence of MDR-resistant 
strains poses major challenges for the prevention and 
treatment of infections caused by K. pneumoniae. K. 
pneumoniae is an important opportunistic pathogen 
responsible for human and animal infections, and the 
emergence of MDR K. pneumoniae has made 
controlling this pathogen difficult worldwide. 
Antibiotic resistance to K. penumoniae isolates 
isolated from pets has been published in several 
countries in Europe, including Germany (Stolle et al., 
2013; Ewers et al., 2014), Italy (Donati et al., 2014), 
France (Haenni et al., 2012; Poirel et al., 2013), Spain 
(Hidalgo et al., 2013), and Switzerland (Wohlwend et 
al., 2015). Brisse and Duijkeren (2005) stated that K. 
pneumoniae isolates collected from dogs and cats were 
resistant to ampicillin, chepalexin, ceftacidime, 
enrofloxacin, gentamicin, and tetracycline. Hong et al. 
(2019) stated that K. pneumoniae isolated from pets 
such as dogs and cats has a resistance gene to the 




Klebsiella pneumoniae isolate from sputum and 
laryngeal swabs of cats in veterinary clinics in Bogor, 
Indonesia has developed Multidrug Resistance (MDR). 
Klebsiella pneumoniae bacteria have been resistant to 
tetracycline, oxytetracycline, gentamicin, enrofloxacin, 
and ampicillin. Further studies are needed to determine 
the activity of genes resistant to each antibiotic. Thus, it 
can be taken into consideration for the use and treatment 
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